Detalhe da pesquisa
1.
Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.
Neoplasma
; 68(3): 626-630, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33567854